Crystal Growth Procedure of HIV-1 Protease-Inhibitor KNI-272 Complex for Neutron Structural Analysis at 1.9 Å Resolution

被引:10
|
作者
Shimizu, Noriko [1 ]
Sugiyama, Shigeru [1 ,6 ]
Maruyama, Mihoko [1 ,6 ]
Takahashi, Yoshinori [1 ,6 ]
Adachi, Motoyasu [2 ]
Tamada, Taro [2 ]
Hidaka, Koushi [3 ]
Hayashi, Yoshio [3 ]
Kimura, Tooru [3 ]
Kiso, Yoshiaki [3 ]
Adachi, Hiroaki [1 ,4 ,6 ]
Takano, Kazufumi [1 ,4 ,6 ]
Murakami, Satoshi [4 ,5 ,6 ]
Inoue, Tsuyoshi [1 ,4 ,6 ]
Kuroki, Ryota [2 ]
Mori, Yusuke [1 ,4 ,6 ]
Matsumura, Hiroyoshi [1 ,4 ,6 ]
机构
[1] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan
[2] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan
[3] Kyoto Pharmaceut Univ, Ctr Frontier Res Med Sci, Dept Med Chem, Kyoto 6078412, Japan
[4] SOSHO Inc, Osaka 5410053, Japan
[5] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan
[6] CREST JST, Suita, Osaka 5650871, Japan
基金
日本科学技术振兴机构;
关键词
LARGE SINGLE-CRYSTAL; STIRRING SOLUTION; CRYSTALLOGRAPHY; CRYSTALLIZATION; DIFFRACTION;
D O I
10.1021/cg100054s
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Neutron protein crystallography is advantageous in determining protonation states of target proteins to provide a more precise understanding of the enzymatic mechanism and accurate structure-based drug design. However, a major obstacle is the growth of large protein crystals needed to compensate for the weak flux of the available neutron beam. Here, we report crystal growth of human immunodeficiency virus 1 protease (HI V PR) in a complex with its inhibitor KNI-272 by six different methods. Comparative analysis indicates that top-seeded solution growth (TSSG) and TSSG combined with the floating and stirring technique (TSSG-FAST) are efficient strategies for rapidly obtaining large single crystals and effectively preventing polycrystallization of the seed crystal. Neutron diffraction analysis confirmed that the crystal obtained by TSSG is a high-quality single crystal. Furthermore, crystal shape was observed to be influenced by solution flow, suggesting that the degree of supersaturation significantly affects the crystal growth direction of HIV PR complex. This finding implies that the shape of the HIV PR complex crystal might be controlled by the solution flow rate.
引用
收藏
页码:2990 / 2994
页数:5
相关论文
共 45 条
  • [1] Crystallization and preliminary neutron diffraction studies of HIV-1 protease cocrystallized with inhibitor KNI-272
    Matsumura, Hiroyoshi
    Adachi, Motoyasu
    Sugiyama, Shigeru
    Okada, Shino
    Yamakami, Megumi
    Tamada, Taro
    Hidaka, Koushi
    Hayashi, Yoshio
    Kimura, Tooru
    Kiso, Yoshiaki
    Kitatani, Tomoya
    Maki, Sho
    Yoshikawa, Hiroshi Y.
    Adachi, Hiroaki
    Takano, Kazufumi
    Murakami, Satoshi
    Inoue, Tsuyoshi
    Kuroki, Ryota
    Mori, Yusuke
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2008, 64 : 1003 - 1006
  • [2] Physiologically based pharmacokinetics of KNI-272, a tripeptide HIV-1 protease inhibitor
    Kiriyama, A
    Nishiura, T
    Yamaji, H
    Takada, K
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1999, 20 (04) : 199 - 205
  • [3] Flexibility and function in HIV protease: Dynamics of the HIV-1 protease bound to the asymmetric inhibitor kynostatin 272 (KNI-272)
    Freedberg, DI
    Wang, YX
    Stahl, SJ
    Kaufman, JD
    Wingfield, PT
    Kiso, Y
    Torchia, DA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (31) : 7916 - 7923
  • [4] Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high-resolution X-ray and neutron crystallography
    Adachi, Motoyasu
    Ohhara, Takashi
    Kurihara, Kazuo
    Tamada, Taro
    Honjo, Eijiro
    Okazaki, Nobuo
    Arai, Shigeki
    Shoyama, Yoshinari
    Kimura, Kaname
    Matsumura, Hiroyoshi
    Sugiyama, Shigeru
    Adachi, Hiroaki
    Takano, Kazufumi
    Mori, Yusuke
    Hidaka, Koushi
    Kimura, Tooru
    Hayashi, Yoshio
    Kiso, Yoshiaki
    Kuroki, Ryota
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (12) : 4641 - 4646
  • [5] Thermodynamic dissection of the binding energetics of KNI-272, a potent HIV-1 protease inhibitor
    Velazquez-Campoy, A
    Luque, I
    Todd, MJ
    Milutinovich, M
    Kiso, Y
    Freire, E
    PROTEIN SCIENCE, 2000, 9 (09) : 1801 - 1809
  • [6] Dynamic flexibility of protein-inhibitor complexes: A study of the HIV-1 protease KNI-272 complex
    Luo, XC
    Kato, RH
    Collins, JR
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (48) : 12410 - 12418
  • [7] Computational study of KNI-272, a potent inhibitor of HIV-1 protease: On the mechanism of preorganization
    David, L
    Luo, R
    Head, MS
    Gilson, MK
    JOURNAL OF PHYSICAL CHEMISTRY B, 1999, 103 (06): : 1031 - 1044
  • [8] Targets of a protease inhibitor, KNI-272, in HIV-1-infected cells
    Goto, T
    Nakano, T
    Kohno, T
    Morimatsu, S
    Morita, C
    Hong, W
    Kiso, Y
    Nakai, M
    Sano, K
    JOURNAL OF MEDICAL VIROLOGY, 2001, 63 (03) : 203 - 209
  • [9] The bioavailability of oral dosage forms of a new HIV-1 protease inhibitor, KNI-272, in beagle dogs
    Kiriyama, A
    Sugahara, M
    Yoshikawa, Y
    Kiso, Y
    Takada, K
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1996, 17 (02) : 125 - 134
  • [10] Bound water molecules at the interface between the HIV-1 protease and a potent inhibitor, KNI-272, determined by NMR
    Wang, YX
    Freedberg, DI
    Wingfield, PT
    Stahl, SJ
    Kaufman, JD
    Kiso, Y
    Bhat, TN
    Erickson, JW
    Torchia, DA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (49) : 12287 - 12290